Nu Skin Enterprises (NUS) Scheduled to Post Earnings on Wednesday

Nu Skin Enterprises (NYSE:NUS) is scheduled to release its earnings data after the market closes on Wednesday, February 14th. Analysts expect Nu Skin Enterprises to post earnings of $1.18 per share for the quarter.

Shares of Nu Skin Enterprises (NYSE NUS) opened at $68.36 on Wednesday. Nu Skin Enterprises has a 1-year low of $47.10 and a 1-year high of $74.45. The firm has a market capitalization of $3,684.45, a PE ratio of 25.04, a price-to-earnings-growth ratio of 2.18 and a beta of 1.46. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.44.

In related news, insider Joseph Y. Chang sold 36,503 shares of the firm’s stock in a transaction that occurred on Friday, November 10th. The stock was sold at an average price of $62.24, for a total transaction of $2,271,946.72. Following the transaction, the insider now directly owns 66,563 shares in the company, valued at approximately $4,142,881.12. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Chairman Steven Lund sold 108,132 shares of the firm’s stock in a transaction that occurred on Friday, December 22nd. The stock was sold at an average price of $68.81, for a total value of $7,440,562.92. Following the transaction, the chairman now owns 4,769 shares in the company, valued at $328,154.89. The disclosure for this sale can be found here. Over the last three months, insiders have sold 232,481 shares of company stock worth $15,784,680. 5.20% of the stock is currently owned by insiders.

Several research firms have weighed in on NUS. ValuEngine raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Friday, February 2nd. Zacks Investment Research cut Nu Skin Enterprises from a “hold” rating to a “sell” rating in a report on Wednesday, December 20th. Finally, Citigroup reissued a “buy” rating and set a $81.00 price objective (up from $70.00) on shares of Nu Skin Enterprises in a report on Tuesday, January 23rd. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $65.38.

ILLEGAL ACTIVITY NOTICE: This article was first published by American Banking News and is owned by of American Banking News. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The correct version of this article can be read at https://www.americanbankingnews.com/2018/02/07/nu-skin-enterprises-nus-scheduled-to-post-earnings-on-wednesday.html.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Earnings History for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply